Insider Transactions in Q4 2025 at Xenon Pharmaceuticals Inc. (XENE)
Insider Transaction List (Q4 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 01
2025
|
Ian Mortimer PRESIDENT, CEO & INTERIM CFO |
SELL
Open market or private sale
|
Direct |
25,000
-44.4%
|
$1,000,000
$40.16 P/Share
|
Oct 01
2025
|
Ian Mortimer PRESIDENT, CEO & INTERIM CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+30.75%
|
$175,000
$7.69 P/Share
|